IMARC Group, a leading market research company, has recently releases report titled, “Infection Surveillance Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global infection surveillance solutions market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
The global infection surveillance solutions market size reached US$ 580.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,177.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028.
Protocols for identifying infections and examining preventive measures are known as infection surveillance solutions. They contain a variety of information that is crucial for a healthcare facility to run well, including information on patient real-time medical records, surgery data, and personnel health. They rely on software that can be customized according to the requirements of the healthcare organization for instant identifications, task completion, and comprehensive surveillance. They assist in diagnosing novel bacteria resistant to antibiotics and various infections that spread through the utilization of unsterilized medical equipment. They are effective in preventing the occurrence of various healthcare-associated infections (HAIs), such as ventilator-associated pneumonia (VAP), central line-associated bloodstream infection (CLABSI), catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI), and skin infections. They keep a detailed track of various infections and diseases while helping healthcare providers reduce the spread of those infections and maintain the health of the patients. They aid in providing quality healthcare to individuals and increasing their recovery rates with appropriate disease management methods. As infection surveillance solutions are used to maintain aseptic environments within the premises, improve efficiency in hygiene maintenance, and restrict the spread of infection-causing microbes, they find extensive applications in hospitals and clinics across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/infection-surveillance-solutions-market/requestsample
One of the major factors propelling the market is the rising need for infection surveillance solutions in the healthcare sector to stop the global spread of catheter-associated urinary tract infections (UTIs), central line-associated bloodstream infections, and VAP. Besides this, there is a rise in the number of surgeries due to the increasing occurrence of chronic and life-threatening diseases. This, coupled with the growing geriatric population across the globe, is positively influencing the market. In addition, governments of various countries are taking measures to make the adoption of infection surveillance solutions mandatory in hospitals, clinics, laboratories, and local public health dispensaries to enhance public health. Apart from this, the growing integration of cloud-based bioinformatics solutions for real-time patient monitoring, spontaneous disease recognition, and management of antibiotic-resistant bacteria is offering a favorable market outlook. Additionally, the rising number of hospitals and nursing homes to provide quality healthcare facilities to individuals is strengthening the growth of the market. Moreover, key market players are investing in research and development (R&D) activities to enhance the functionality of infection surveillance solutions with artificial intelligence (AI) and the internet of things (IoT), which is bolstering the growth of the market.
The report has segmented the market into the following categories:
Breakup by Component:
Breakup by Deployment Type:
Breakup by End User:
Breakup by Region:
The report covers the major market players including:
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4857&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
